For: | Wang KM, Wei SP, Yin XY, Meng QJ, Kong YM. Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence. World J Clin Cases 2022; 10(21): 7324-7332 [PMID: 36158017 DOI: 10.12998/wjcc.v10.i21.7324] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i21/7324.htm |
Number | Citing Articles |
1 |
Shenggen Wang. Alendronate sodium demonstrates significant clinical advantages in treating osteoporosis secondary to severe fractures. American Journal of Translational Research 2025; 17(6): 4516 doi: 10.62347/MFPV8667
|
2 |
Kaitao Yao, Qian Zhang, Lian Weng, Shuyang Li, Xuzhou Zheng, Liqun Hu, Yuxi Luo, Xiaoyu Huang, Zhangfan Gong, Zi Wang, Chang Liu, Jiyuan Yan, Jianhua Ge, Xingtao Chen, Yiran Yin. Cerium-Doped, Alendronate-Loaded, Metal–Organic Framework Nanodrug for Delayed Osteoporosis Progress. ACS Applied Nano Materials 2024; 7(24): 28504 doi: 10.1021/acsanm.4c05640
|
3 |
Xiaoyang Zheng, Caihong Zhu, Rui Zhang, Hongyu Sun. Assessing the Risk of Osteoporotic Fracture Recurrence Using CT-based Radiomics and Machine Learning. Current Problems in Surgery 2025; : 101876 doi: 10.1016/j.cpsurg.2025.101876
|